| SNo | Date | Information | Download |
| # | 18/01/2022* | Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) |  |
| # | 14/01/2022* | Clinical Guidance for Management of Adult COVID-19 Patients | |
| # | 08/11/2021* | Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) | |
| # | 02/08/2021* | Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) | |
| # | 28/06/2021* | Details of National Task Force (NTF) and its research groups meetings on COVID-19 (Diagnostic Group, Epidemiology & Surveillance Working Group (ESWG), Operational Research (OR) Group & Clinical Research Group (CRG)) | |
| # | 06/08/2020 | Invitation for submitting Letter of Intent for Participation in National Clinical Registry of COVID-19 | |
| # | 30/07/2020 | Agenda of International Symposium on Novel Ideas in Science and Ethics of Vaccines against COVID-19 pandemic on July 30, 2020 | |
| # | 23/07/2020 | Establishing of a network of Biorepositories in India | |
| # | 23/05/2020 | Establishing of a network of Biorepositories in India | |
| # | 22/05/2020 | Establishing of a network of Biorepositories in India | |
| # | 22/05/2020 | List of approved institutions for PLACID Trial | |
| # | 15/05/2020 | List of approved institutions for PLACID Trial | |
| # | 11/05/2020 | List of approved institutions for PLACID Trial | |
| # | 10/05/2020 | List of approved institutions for PLACID Trial | |
| # | 08/05/2020 | List of approved institutions for PLACID Trial | |
| # | 04/05/2020 | List of approved institutions for PLACID Trial | |
| # | 21/04/2020* | Call for proposals under the TF on Translational Immunology | |
| # | 12/04/2020 | Call for Letter of Intent for Participation in: Therapeutic Plasma Exchange in COVID-19: Protocol for a Multi-center, Phase II, Open Label, Randomized Controlled Study | |
| # | 12/04/2020 | Call for Letter of Intent for Participation in: A Phase II, Open Label, Randomized Controlled Study to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications | |
| # | 03/04/2020 | Therapeutic trial for COVID-19 | |
| SNo | Date | Information | Download |
| # | 23/09/2021 | Clinical Guidance for Management of Adult COVID-19 Patients | |
| # | 17/05/2021 | Clinical Guidance for Management of Adult COVID-19 Patients | |
| # | 18/01/2021* | Restricted Use of COVAXINTM Under Clinical Trial Mode (Implementation Plan No: BBIL/COVAXINTM/2021) | |
| # | 26/11/2020 | Advisory on use of Dry Swab RNA Extraction Free RTPCR Method | |
| # | 22/03/2020 | Recommendation for empiric use of hydroxy-chloroquine for prophylaxis of SARS-CoV-2 infection | |
Website Content Owned by
Indian Council of Medical Research, DHR, MoHFW, GoI
Website Hosted By :
National Informatics Centre